Dow Jones

40,211.72

0.53%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) News

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALTH

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

Date	Time	Source	Headline	Symbol	Company
20/07/2011	22:21	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	21:05	Business Wire	Law Office of Brodsky & Smith, LLC Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	17:39	Business Wire	The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	17:16	Business Wire	Harwood Feffer LLP Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	15:37	Business Wire	Kendall Law Group Investigates Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	15:37	Business Wire	Faruqi & Faruqi, LLP Announces Investigation of Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	13:01	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	12:54	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	12:52	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	12:49	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	12:48	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	12:47	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	12:46	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	12:00	Business Wire	AMAG Pharmaceuticals and Allos Therapeutics Agree to Merge to Strengthen Commercial Portfolio and Achieve Cost Synergies	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/07/2011	21:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/07/2011	22:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/06/2011	21:28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/06/2011	21:27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/06/2011	21:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/06/2011	21:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/06/2011	21:24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/06/2011	21:23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/06/2011	21:11	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/06/2011	14:30	Zacks	Label Expansion for CELG's Istodax - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	22:29	Business Wire	Data Shows Activity of FOLOTYN® in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Following Treatment with ...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	14:00	Marketwired	Research Report on Allos Therapeutics, Inc. and Spectrum Pharmaceuticals, Inc. -- BioPharm Looks Forward for Growth	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	11:50	GlobeNewswire Inc.	Allos Therapeutics is MicroStockProfit.com's Biopharm Feature Stock	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	07:30	Business Wire	Data Suggests Treatment with FOLOTYN® Reverses Trend of Progressive Resistance Observed in Patients with Drug-Resistant Rela...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
16/06/2011	07:30	Business Wire	COMPLETE Registry Provides First Glance into Treatment Patterns for Patients with Peripheral T-Cell Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
08/06/2011	14:00	Business Wire	FOLOTYN® Data to be Presented at the Congress of the European Hematology Association & the International Conference on Malig...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)